1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      A high level of clinical response is associated with improved patient-reported outcomes in psoriasis: analyses from a phase 2 study in patients treated with ixekizumab.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          J Eur Acad Dermatol Venereol
          Journal of the European Academy of Dermatology and Venereology : JEADV
          Wiley
          1468-3083
          0926-9959
          May 2016
          : 30
          : 5
          Affiliations
          [1 ] Eli Lilly and Company, Indianapolis, IN, USA.
          [2 ] Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
          [3 ] St. Louis University School of Medicine, St. Louis, MO, USA.
          Article
          10.1111/jdv.13032
          25773781
          0b990d7a-d723-4fef-8d3e-ba031b8d012a
          History

          Comments

          Comment on this article